Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111747971A details a novel phenothiazine dioxide-based perylene diimide material offering superior stability and cost efficiency for next-generation photovoltaic manufacturing.
Novel process for Tylvalosin precursor using Tylosin Tartrate. High yield, simplified steps, reduced solvent use. Ideal for veterinary API manufacturing.
Patent CN1377337A details a novel route for COX-2 inhibitor intermediates via lactam hydrolysis. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Explore the synthesis of novel phenylethanolamine compounds for asthma treatment. Discover cost-effective manufacturing routes and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN101314581B details a gold-catalyzed synthesis of N-sulfonyl ketimines offering mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Novel synthesis avoids toxic amines. High purity hole transport materials. Cost-effective scale-up for display industry.
Patent CN113336665B reveals a metal-free route for arylamide synthesis using hypervalent iodine. This method offers mild conditions and high purity for pharmaceutical intermediates.
Novel reductive amination route for influenza inhibitor intermediates. High yield, safe scale-up, and cost-effective manufacturing solution for global pharma.
Patent CN112479968A reveals a room-temperature hydroamination route using KI/KHSO4, offering a cost-effective alternative to transition metals for pharmaceutical intermediates.
Patent CN117327010A reveals a novel Pd-catalyzed C-H amination route for high-purity 3-tert-butylaminoacrylamide derivatives, offering significant supply chain and cost advantages.
Novel preparation method for Maraviroc derivatives using gamma-position azide compounds. Offers mild conditions, high purity, and cost-effective scale-up for API manufacturing.
Patent CN107793351A reveals advanced C-H amination for beta amino acids. Enables cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains globally.
Patent CN107793351B details a novel Pd-catalyzed route to diverse beta-amino acids, offering mild conditions and structural variety for API intermediate manufacturing.
Patent CN112209837A reveals a novel reductive amination route for Butenafine HCl, offering superior purity and cost reduction in API manufacturing compared to traditional chloromethylation methods.
Patent CN109824539B details a novel 6-step Tigecycline synthesis from Demethyl Aureomycin, offering high purity, cost reduction, and scalable manufacturing for pharmaceutical intermediates.
Patent CN108395408B details a scalable route for [4-(1,1-difluoro-ethyl)-pyrimidine]-5-methanamine. Achieve cost reduction in API manufacturing with this efficient aqueous reduction strategy.
Patent CN102712593B reveals improved synthesis using hydrophilic ethers. Achieves high purity and reduced reaction time for scalable pharmaceutical intermediates manufacturing.
Novel patent CN104945265B offers high-yield 2-aminoindene synthesis. Reduces costs and improves supply chain reliability for global pharma manufacturers.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Novel 4-step route for Elacestrant intermediate. High purity, scalable process for pharmaceutical supply chain cost reduction and efficiency.